Antiviral properties of a mangrove plant, Rhizophora apiculata Blume, against human immunodeficiency virus

Antiviral Research

Volumn 44, Issue 2, 1999, Pages 113-122

  Premanathan, Mariappan ^a   Arakaki, Rieko ^a   Izumi, Hiroyuki ^a   Kathiresan, Kandasamy ^b   Nakano, Masatoshi ^c   Yamamoto, Naoki ^d   Nakashima, Hideki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b ANNAMALAI UNIVERSITY   (India)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Anti HIV activity; Human immunodeficiency virus; Indirect immunofluorescence assay; Polysaccharide; Rhizophora apiculata; Rhizophoraceae

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIGEN P24; MESSENGER RNA; PLANT EXTRACT; POLYSACCHARIDE; THROMBOPLASTIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MONONUCLEAR CELL; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PLANT LEAF; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; SYNCYTIUM; VIRION; VIRUS ADSORPTION; VIRUS INHIBITION;

ANTI-HIV AGENTS; ANTICOAGULANTS; CELLS, CULTURED; CYTOPATHOGENIC EFFECT, VIRAL; GIANT CELLS; HIV-1; HIV-2; HUMANS; PLANT EXTRACTS; POLYSACCHARIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROSALES; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; RHIZOPHORA APICULATA; RHIZOPHORACEAE; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0032761581     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(99)00058-3     Document Type: Article

References (28)

1. Baba M., De Clercq E., Schols D., Pauwels R., Snoeck R., Boeckel C.V., Dedem G.V., Kraaijeveld N., Hobbelen P., Ottenhemijm H., Hollander F.D. Novel sulfated polysaccharides: dissociation of anti-human immunodeficiency virus activity from antithrombin activity. J. Infect. Dis. 161:1990;208-213.
2. Baba M., Shigeta S., Yuasa S., Takashima H., Sekiya K., Ubasawa M., Tanaka H., Miyasaka T., Walker R.T., De Clercq E. Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro. Antimicrob. Agents Chemother. 38:1994;688-692.
3. Bagasra O., Lischner H.W. Activity of dextran sulfate and other polyanionic polysaccharides against human immunodeficiency virus. J. Infect. Dis. 158:1988;1084-1087.
4. Bitter T., Muir H.M. A modified uronic acid carbazole reaction. Anal. Biochem. 4:1962;330-334.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:1976;248-254.
6. Chackerian B., Long E.M., Luciw P.A., Overbaugh J. Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J. Virol. 71:1997;3932-3939.
7. Condra J.H., Schleif W.A., Blahy O.M., Gabryelski L.J., Graham D.J., Quintero J.C., Rhodes A., Robbins H.L., Roth E., Shivaprakash M., Titus D., Yang T., Teppler H., Squires K.E., Deutsch P.J., Emini E.A. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature (London). 374:1995;569-571.
8. Dalgleish A.G., Beverley P.C.L., Clapham P.R., Crawford D.H., Greaves M.F., Weiss R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 312:1984;763-767.
9. Dodgson K.S. Determination of inorganic sulphates in studies on the enzymic and non-enzymic hydrolysis of carbohydrate and other sulphate esters. Biochem. J. 78:1961;312-319.
10. Dubois M., Gilles K.A., Hamilton J.K., Rebers P.A., Smith F. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28:1956;350-356.
11. Hartman N.R., Johns D.J., Mitsuya H. Pharmacokinetic analysis of dextran sulfate in rats as pertains to its clinical usefulness for therapy of HIV infection. AIDS Res. Hum. Retroviruses. 6:1990;805-812.
12. Hayakawa M., Ogawa T., Sugiyama S., Tanaka M., Ozawa T. Massive conversion of guanosine to 8-hydroxy-guanosine in mouse liver mitochondrial DNA by administration of azidothymidine. Biochem. Biophys. Res. Commun. 176:1991;87-93.
13. Kimpton J., Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66:1992;2232-2239.
14. Kirtikar K.R., Basu B.D. Indian Medicinal Plants. 1935;2793 Lalit Mohan Basu, Allahabad, India.
15. Klatzmann D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J.C., Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 312:1984;767-768.
16. Lang W., Osmond D., Page-Bodkin K., Moss A., Winkelstein W. Jr. Population-based estimates of antiretroviral therapy and anti-pneumocystis prophylaxis in San Francisco: 1991. J. Acq. Immune Defic. Syndr. 6:1993;191-195.
17. Lorentsen K.J., Hendrix C.W., Collins J.M., Kornhauser D.M., Petty B.G., Klecker R.W., Flexner C., Eckel R.H., Lietman P.S. Dextran sulfate is poorly absorbed after oral administration. Ann. Intern. Med. 111:1989;561-566.
18. Pauwels R., Balzarini J., Baba M., Snoeck R., Schols D., Herdewijn P., Desmyter J., De Clercq E. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods. 20:1988;309-321.
19. Pearce-Pratt R., Phillips D.M. Studies of adhesion of lymphotropic cells: implications for sexual transmission of HIV. Biol. Reprod. 48:1993;431-445.
20. Premanathan M., Nakashima H., Kathiresan K., Rajendran N., Yamamoto N. In vitro anti human immunodeficiency virus activity of mangrove plants. Indian J. Med. Res. 103:1996;278-281.
21. Premanathan M., Nakashima H., Igarashi R., Mizushima Y., Yamada K. Lecithinized superoxide dismutase: an inhibitor of human immunodeficiency virus replication. AIDS Res. Hum. Retroviruses. 13:1997;283-290.
22. Premanathan M., Arakaki R., Ramanan S., Jinno S., Baba M., Yamashita S., Nakashima H. 3-(5-Dimethylamino-1-naphthalesulphonyl)-2-(3-pyridyl) thiazolidine (YHI-1) selectively inhibits human immunodeficiency virus type 1. Antiviral Chem. Chemother. 9:1998;423-430.
23. Richman D.D., Fischl M.A., Grieco M.H., Gottlieb M.S., Volberding P.A., Liskin O.L., Leedom J.M., Groopman J.E., Mildvan D., Hirsch M.S., Jackson G.G., Durack D.T., Phil D., Nusinoff-Lehrman S. The toxicity of Azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex, a double blind, placebo controlled trial. New Engl. J. Med. 317:1987;192-197.
24. Schols D., Baba M., Pauwels R., De Clercq E. Flow cytometric method to demonstrate whether anti-HIV-1 agents inhibit virion binding to T4+ cells. J. Acquir. Immune Defic. Syndr. 2:1989;10-15.
25. Seki M., Sadakata Y., Yuasa S., Baba M. Isolation and characterization of human immunodeficiency virus type1 mutants resistant to the non-nucleotide reverse transcriptase inhibitor MKC-442. Antiviral Chem. Chemother. 6:1995;73-79.
26. Stafford M.K., Cain D., Rosenstein I., Fontaine E.A., McClure M., Flanagan A.M., Smith J.R., Taylor-Robinson D., Weber J., Kitchen V.S. A placebo-controlled, double-blind prospective study in healthy female volunteers of dextrin sulphate gel: a novel potential intravaginal virucide. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14:1997;213-218.
27. Tochikura T.S., Nakashima H., Tanabe A., Yamamoto N. Human immunodeficiency virus (HIV)-induced cell fusion: quantification and its application for the simple and rapid screening of anti-HIV substances in vitro. Virology. 164:1988;542-546.
28. Vandamme A.-M., Debyser Z., Pauwels R., De Vreese K., Goubau P., Youle M., Gazzard B., Stoffels P.A., Cauwenbergh G.F., Anne J., Andries K., Janssen P.A.J., Desmyter J., De Clercq E. HIV-1 strains isolated from patients treated with TIBO R82913. AIDS Res. Hum. Retroviruses. 19:1994;39-46.